Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Zhenglun Zhu"'
Publikováno v:
iScience, Vol 27, Iss 1, Pp 108731- (2024)
Summary: Immune suppression within tumor microenvironments (TME) have been implicated in limited efficacy of immune check point inhibitors (ICIs) against solid tumors. Down-regulated VentX expression in tumor associated macrophages (TAMs) underlies p
Externí odkaz:
https://doaj.org/article/ba52bae135fe42ffa501c894e4157e21
Publikováno v:
PeerJ, Vol 11, p e15156 (2023)
Background Intra-abdominal fat volume (IFV) has been shown to have a negative impact on surgical outcomes in gastric cancer (GC) and other gastrointestinal surgeries. The purpose of this study is to look into the relationship between IFV and perioper
Externí odkaz:
https://doaj.org/article/800253d5996e47cab2a06ef065d2ac05
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 4, Pp 518-532 (2022)
Objective: To quantify the potential benefit of adjuvant chemotherapy (ACT) with respect to survival, and to identify factors for predicting prognoses in early gastric cancer patients. Methods: Patients with pT1 gastric cancer (GC) who underwent radi
Externí odkaz:
https://doaj.org/article/a982255d8ed046b1816979d752cdaba0
Autor:
Min Shi, Zhongyin Yang, Sheng Lu, Wentao Liu, Zhentian Ni, Xuexin Yao, Zichen Hua, Runhua Feng, Yanan Zheng, Zhenqiang Wang, Birendra Kumar Sah, Mingmin Chen, Zhenglun Zhu, Changyu He, Chen Li, Jun Zhang, Chao Yan, Min Yan, Zhenggang Zhu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background In this study, we tried to access the efficacy and safety of oxaliplatin plus S-1 with intraperitoneal paclitaxel (PTX) for the treatment of Chinese advanced gastric cancer with peritoneal metastases. Patients and methods Thirty p
Externí odkaz:
https://doaj.org/article/6f7c9766eb52403c99e7cb1a5b30938f
Publikováno v:
iScience, Vol 25, Iss 11, Pp 105426- (2022)
Summary: Limited therapeutic efficacy and severe side effects represent the central hurdles facing cancer chemotherapy. Immune suppression within tumor immune microenvironments (TIME) has been implicated in chemoresistance. In this study, using a TIM
Externí odkaz:
https://doaj.org/article/4debbb58e93942a297c34046442264bd
Autor:
Birendra Kumar Sah, Benyan Zhang, Huan Zhang, Jian Li, Fei Yuan, Tao Ma, Min Shi, Wei Xu, Zhenglun Zhu, Wentao Liu, Chao Yan, Chen Li, Bingya Liu, Min Yan, Zhenggang Zhu
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-8 (2020)
Neoadjuvant FLOT regimen has shown promising results for the treatment of locally advanced gastric cancer, however SOX regimen remains the preferred chemotherapy in Eastern countries. Here the authors report that the two therapies result in similar o
Externí odkaz:
https://doaj.org/article/69c89493ee9f46c0a12be336365c16b6
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: There is no global consensus on adjuvant chemotherapy (ACT) for pT2N0M0 gastric cancer. We conducted a retrospective study to reveal the role of ACT in such patients.Methods: Patients with pT2N0M0 gastric cancer who underwent radical rese
Externí odkaz:
https://doaj.org/article/9bbc11f16f9d4a2ca2f9052a2137d239
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Objective: We aimed to establish a nomogram for predicting lymph node metastasis in early gastric cancer (EGC) involving human epidermal growth factor receptor 2 (HER2).Methods: We collected clinicopathological data of patients with EGC who underwent
Externí odkaz:
https://doaj.org/article/4f44429e985c4324b3645f26d5a39306
Autor:
Hong-Peng Shi, Wei Wu, Ben-Yan Zhang, Maneesh-Kumarsing Beeharry, Tie-Nan Feng, Zheng-Gang Zhu, Fei Yuan, Zhenglun Zhu
Publikováno v:
Videosurgery and Other Miniinvasive Techniques, Vol 16, Iss 1, Pp 45-53 (2020)
Externí odkaz:
https://doaj.org/article/4c60494468cb4cbf89fe563c5aa3e3e7
Autor:
Wei Xu, Wentao Liu, Lingquan Wang, Changyu He, Sheng Lu, Zhentian Ni, Zichen Hua, Zhenglun Zhu, Birendra Kumar Sah, Zhongyin Yang, Yanan Zheng, Runhua Feng, Chen Li, Xuexin Yao, Mingmin Chen, Chao Yan, Min Yan, Zhenggang Zhu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundFor gastric cancer (GC) with extensive lymph node metastasis (bulky N2 and/or para-aortic lymph node metastases), there is no standard therapy worldwide. In Japan, preoperative chemotherapy (PCT) followed by D2 gastrectomy plus para-aortic
Externí odkaz:
https://doaj.org/article/04b341507fe54a4fb9602241c239e151